| Product Name | NebuSelect™ Recombinant Human CD21, His-tag |
|---|---|
| Catalog Number | NBL-242947 |
| Alias/Synonyms | CD21; EBV receptor; CD21; C3DR; CR2;C3DRSLEB9; CVID7; SLEB9 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P20023-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242947-100ug | 100ug | Inquire | Inquire | |
| NBL-242947-1mg | 1mg | Inquire | Inquire | |
| NBL-242947-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD21, His-tag
Catalog#:
NBL-242947
Description:
NebuSelect™ Recombinant Human CD21, His-tag(Cat#NBL-242947) is expressed in HEK293 with His tag at the C-Terminus.It contains Ile21-Arg971.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 105.3 kDa. Due to glycosylation, the protein migrates to 110-130 kDa based on Bis-Tris PAGE result.
Target Name:
CD21; EBV receptor; CD21; C3DR; CR2;C3DRSLEB9; CVID7; SLEB9
Target Information:
CD21 mRNA expression, an EBV-entry receptor, was transiently detected in NK cells after exosome treatment, and levels decreased after further culture. CD21 protein expression was also transiently transferred to NK cells after co-culture with an EBV-positive Burkitt lymphoma cell line (Raji) via trogocytosis. However, EBV did not infect NK cells through CD21-mediated trogocytosis.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.